Factors Influencing Chemotherapy-Induced Taste Alterations in Cancer Patients Receiving Cisplatin Treatment: A Path Analysis
Cancer Control · 2025
DOI: 10.1177/10732748251363323 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Control, 2025. Verfasst von Berna Kurt und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medical Nursing, Hacettepe University, Ankara, Turkey. Hauptthemen laut MEDLINE: Cisplatin, Neoplasms, Antineoplastic Agents, Taste Disorders. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Themen: Onkologische Pflege
Abstract (Originalsprache)
Introduction
Cisplatin is particularly recognized for its adverse effects, most notably its impact on chemosensory perception.
Methods
This cross-sectional study enrolled 98 cancer patients undergoing cisplatin therapy from April 2022 to December 2023. Patients were administered the Chemotherapy-Induced Taste Alteration Scale (CITAS) and the Rhodes Index of Nausea, Vomiting, and Retching (RINVR).
Results
A multiple linear regression model was employed to determine the effect of taste changes among cancer patients undergoing cisplatin therapy. The study of the model coefficients for the structural model (χ 2 /df = 1.338, P = .004, GFI = 0.955, CFI = 0.986, RMSEA = 0.063, SRMR = 0.079) demonstrated a robust match. This model, formed to evaluate the effects of taste alteration, appetite loss, nausea, vomiting, age, quality of life, and body surface area, was statistically significant and explained 76.4% of the variation. Multiple linear regression evaluations determined significant factors affecting taste alteration associated with nausea-vomiting [(95% CI: 0.111-0.244); P = 0.042], loss of appetite [(95% CI: 0.102-0.254); P = 0.000], age [(95% CI: −0.827-0.424); P = 0.001], quality of life [(95% CI: −0.908-0.489); P = 0.000], and body surface area [(95% CI: 0.024-0.098); P = 0.021].
Conclusion
Taste alteration significantly influenced symptoms of appetite loss, nausea, vomiting, age, and body surface area. These results provide valuable insights for developing effective intervention strategies to alleviate the relational effects of symptom clusters on patients’ quality of life and symptoms, particularly for cancer patients receiving cisplatin therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medical Nursing, Hacettepe University, Ankara, Turkey.
- Department of Internal Medical, Dr Abdurrahman Yurtaslan Oncology Training and Research Hospital, Ankara, Turkey.
ORCID-Profile: Berna Kurt
Zitieren
APA
Kurt, B., & Öksüzoğlu, B. Ö. Ç. (2025). Factors Influencing Chemotherapy-Induced Taste Alterations in Cancer Patients Receiving Cisplatin Treatment: A Path Analysis. Cancer Control. https://doi.org/10.1177/10732748251363323
Vancouver
Kurt B, Öksüzoğlu BÖÇ. Factors Influencing Chemotherapy-Induced Taste Alterations in Cancer Patients Receiving Cisplatin Treatment: A Path Analysis. Cancer Control. 2025. doi:10.1177/10732748251363323
BibTeX
@article{Kurt2025,
author = {Kurt, Berna and Öksüzoğlu, Berna Ömür Çakmak},
title = {Factors Influencing Chemotherapy-Induced Taste Alterations in Cancer Patients Receiving Cisplatin Treatment: A Path Analysis},
journal = {Cancer Control},
year = {2025},
doi = {10.1177/10732748251363323}
}
EUVIMED